Mr. Agrawal has published extensively in Breast and General Surgery. Publications in Breast Surgery are listed below.

Publications in Breast Surgery

http://www.researchgate.net/profile/Amit_Agrawal13

http://www.ncbi.nlm.nih.gov/pubmed/?term=agrawal%2C+breast%2C+nottingham

2016

Assessment and Planning for Oncoplastic and Reconstructive breast surgery: a Review and a proposed Chart
Agrawal A
Eur J Plast Surgery. (), 1-10. DOI 10.1007/s00238-016-1221-7. Online first 14 July 2016

Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effect based on sequential biopsies 
Agrawal A, Robertson JFR, Gutteridge E, Cheung KL, Ellis IO, Nicholson RI, Gee JMW
Int J Cancer. 2016 Jan 1; 138(1): 146-59. Epub 2015 Jul 30 [PMID: 26178788]

Book Chapters

World Breast Cancer Report, 2012. Chapter 22: Breast Cancer around the World: United Kingdom
Agrawal A, Sibbering DM
World Breast Cancer Report, 2012. Pg 229-236. In: Boyle P et al (Eds).
International Prevention Research Institute, Lyon, France. Funded by Susan G. Komen Foundation

Fulvestrant – Metastatic disease
Agrawal A, Cheung KL, Robertson JFR
Oxford Oncology Library. Chapter 5, In: Buzdar AU (ed), Endocrine Therapies in Breast Cancer,
Oxford University Press, UK; 2007 September

Technical Innovation

A simple plunger technique for negative pressure during fat harvesting
Agrawal A, Rasheed T
J of Plastic, Reconstructive & Aesthetic Surgery. 2013 Dec; 67(4):e105-e106

Original Articles

Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effect based on sequential biopsies 
Agrawal A, Robertson JFR, Gutteridge E, Cheung KL, Ellis IO, Nicholson RI, Gee JMW
Int J Cancer. 2016 Jan 1; 138(1): 146-59. Epub 2015 Jul 30 [PMID: 26178788]

Changing Trends in Consultant Practice and Breast Training in the United Kingdom
MaraqaL, Agrawal A, Macmillan RD, Gutteridge E, Whisker L, Horgan K, Rainsbury RM, and Association of BreastSurgeons
Bulletin of the RCS of England. 2015 Apr; 97(4):E11-E14(4)

Pilot randomised study of early intervention based on tumour markers in the follow-up of patients with primary breast cancer
J Mathew, Prinsloo P, Agrawal A, Gutteridge E, Marenah C, Robertson JFR, Cheung KL
The Breast. 2014 Oct; 23(5):567-72 [PMID: 24874285]

Surgical & Oncological outcome after skin sparing mastectomy and immediate breast reconstruction
Agrawal A, Grewal M, Sibbering DM, Courtney CA
Clin Breast Cancer. 2013 Dec; 13(6):478-81 [PMID: 24119787]

Clinical relevance of “withdrawal therapy” as a form of hormonal manipulation for breast cancer
Agrawal A, Robertson JFR, Cheung KL
World J SurgOncol. 2011 Sep 9;9(1):101 [PMID: 21906312]

Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in premenopausal women
Cheung KL, Agrawal A, Folkerd E, Dowsett M, Robertson JFR, Winterbottom
Eur J Cancer. 2010 November; 46(16): 2936-2942 [PMID: 20832294]

The effects of Gefitinib in Tamoxifen resistant &hormone insensitive Breast Cancer:A Phase II study
Gutteridge E, Agrawal A, Nicholson RI, Cheung KL, Robertson JFR, Gee JMW
Int J Cancer. 2010 Apr 15; 126(8): 1806-1816 [PMID: 19739079]

Bone turnover markers in postmenopausal breast cancer patients treated with Fulvestrant
Agrawal A, Hannon RE, Cheung KL, Eastell R, Robertson JFR
The Breast. 2009 June; 18(3):204-7 [PMID: 19464177]

Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy
Okunade G, Green AR, Ying M, Agrawal A, Paish EC, Aleskandrany M, Winterbottom L, Hassell K, Morgan DAL, Ellis IO, Cheung KL
Crit Rev OncolHematol. 2009 Oct; 72(1):76-82. Epub 2009 Jun 9 [PMID: 19515574]

Primary endocrine therapy in locally advanced breast cancers-the Nottingham experience
Mathew J, Agrawal A, AsgeirssonKS, Buhari A, Jackson LR, Cheung KL, Robertson JF
Breast Cancer Res Treat. 2009 Jan; 113(2): 403-7 [PMID: 18311583]

Can CT scan replace bone scan in detecting bony metastases from breast cancer? A prospective audit
Bristow AR, Agrawal A, Burrell HC, Cornford EJ, Evans AJ, James JJ, Hamilton L, Robertson JFR, Chan SY, LawtonPA, Cheung KL
The Breast. 2008 Feb; 17 (1): 100-105 [PMID: 17890090]

Serum EGFR and HER2 expression in primary and metastatic breast cancer patients
AsgierssonKS, Agrawal A, Allen C, Hitch A, Ellis IO, Chapman C, Cheung KL, Robertson JFR
Breast Cancer Research. 2007 Nov 01; 9(6): R75 [PMID: 17976236

Oesophagogastric cancers secondary to a breast primary do not require resection
Ayantunde A, Agrawal A, Parsons SL, Welch NT
World J Surg. 2007 Aug; 31(8): 1597-601 [PMID: 17578645]

Neoadjuvant chemotherapy in locally advanced primary breast cancers – The Nottingham experience
Mathew J, Asgiersson KS, Agrawal A, Mukherjee A, Cheung KL, Chan SY, Robertson JFR
Eur J SurgOncol. 2007 Oct; 33(8): 972-976 [PMID: 17391905]

The Use of LatissimusDorsiMiniflap for Reconstruction following Breast Conserving Surgery:
Experience of a Small Breast Unit in a District Hospital
Navin C*, Agrawal A*, Kolar KM [* = equal 1st author contribution]
World J Surg. 2007 Jan; 31(1): 46-50 [PMID: 17180559]

Efficacy and tolerability of high dose ethinylestradiol in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents
Agrawal A, Robertson JFR, Cheung KL
World J SurgOncol. 2006 Jul 11; 4(1): 44 [PMID: 16834778]

“Resurrection of clinical efficacy” after resistance to endocrine therapy in metastatic breast cancer
Agrawal A, Robertson JFR, Cheung KL
World J SurgOncol. 2006 Jul 5; 4(1): 40 [PMID: 16822312]

Review Articles

Skin sparing mastectomy and immediate breast reconstruction: A Review
Agrawal A, Sibbering DM, Courtney CA
Eur J SurgOncol. 2013 April; 39: 320-328 [PMID: 23333068]

Male Breast Cancer : A Review of Clinical Management
Agrawal A, Ayantunde AA, Rampaul R, Robertson JFR
Breast Cancer Res Treat. 2007 May; 103(1): 11-21 [PMID: 17033919]

A review of concepts of seroma formation and prevention in breast cancer surgery
Agrawal A, Ayantunde AA, Cheung KL
ANZ J Surg. 2006 Dec; 76(12): 1088-1095. Commentary: 1046 [PMID: 17199696]

The ‘other half’ of breast cancer – A review of male breast cancer
Ying M, Agrawal A, Cheung KL
The Journal of Men’s Health & Gender. 2005 Dec; 2(4): 406-413

Overview of tyrosine kinase inhibitors in clinical breast cancer
Agrawal A, Gutteridge E, Gee JMW, NicholsonRI, Robertson JFR
EndocrRelat Cancer. 2005 Jul; 12 (Suppl 1): S135-44 [PMID: 16113090]

Mesh migration following laparoscopic repair of inguinal hernia: a case report and review of literature
Agrawal A, Avill R
Hernia. 2006 Mar; 10(1): 79-82 [PMID: 16258705]

Case Reports

Invasive Lobular carcinoma arising in accessory breast tissue
Devine C, Courtney CA, Deb R, Agrawal A
World J SurgOncol. 2013 Feb 26; 11(1):47 [PMID: 23442311]

Adenosquamous carcinoma of breast in a 19 years old woman: A Case report
Agrawal A, Saha S, Ellis IO, Bello AM
World J SurgOncol. 2010 May 27; 8(1):44 [PMID: 20507552]

Fulvestrant in advanced Male Breast Cancer 
Agrawal A, Cheung KL, Robertson JFR
Breast Cancer REs Treat. 2007 Jan; 101(1):123 [PMID: 16807672]

 

PRESENTATIONS in INTERNATIONAL/NATIONAL CONFERENCES

 

Use of combination of modules of BREAST-Q in partial breast reconstruction with lateral chest wall flap
Mirsekhar-Syahkal B, Agrawal A                                                                                                                                                                      Eur J Surg Oncol. May 2016; 42(5): S39.

National meeting of Association of Breast Surgery (ABS), Manchester, UK

 

Neo-adjuvant chemotherapy, tumour biology and the degree of response – A Surgeon’s perspective 

Greensmith M, PsychogiouV, BensonJ, ForouhiP, Provenzano E, Agrawal A

Eur J Surg Oncol. May 2016; 42(5): S44.

National meeting of Association of Breast Surgery (ABS), Manchester, UK

 

A chart for rapid comprehensive assessment and planning for Oncoplastic and Reconstructive Breast Surgery

Agrawal A

Eur J Surg Oncol. June 2015; 41(6):S46

National meeting of Association of Breast Surgery (ABS), Bournemouth, UK

 

Remit of Modern Oncoplastic Breast Surgery

S Gupta Cancer Care and Research Centre, 02 July 2015, Thakurpukur-Kolkata, India
Implications of Adjuvant therapy on Oncoplastic Breast Surgery

National meeting of Asso. of Breast Surgeons of India, 26-28 June 2015, Indore, India

 

Lateral chest wall perforator flaps partial reconstruction of the breast following WLE

National meeting of Asso. of Breast Surgeons of India, 16-20 June 2014, Kolkata, India

 

Medium and long term biological effects of fulvestrant on ER positive human breast cancer

Agrawal A, Robertson JFR, Guteridge E, Ellis IO, Cheung KL, Nicholson RI, Kyme S, Gee JM

British Breast Group, 31 January 2014, York, UK

 

Future trends in Breast Cancer Care

Derby Breast Cancer Patient Support Group, 05 September 2013, Derby, UK

 

Introduction of Enhanced Recovery After Surgery (ERAS) Pathways in LD Flap reconstruction

Watts H, Laurie K, Agrawal A, Gutteridge E, Gough J, Farmery R, crimshire H, Whisker L

Eur J Surg Oncol, 2014; 40(5): Pg 623 (Abs No P048).

National meeting of Association of Breast Surgery (ABS), Liverpool, UK

3rd ERAS UK Conference Proc, 08 November 2013 (Abs No 811029), Birmingham, UK
Relevance of rise in CA15.3 during fulvestrant therapy in advanced breast cancer patients

Agrawal A, Bathmapriya B, Cheung KL, Robertson JFR

Meeting of American Society of Clinical Oncology: e11567, June 2013, Chicago, UK
Changing Trends in Consultant Practice and Breast Training in the United Kingdom

Maraqa L, Agrawal A, Macmillan RD, Gutteridge E, Whisker L, Rainsbury RM, MacNeill F, ABS

Eur J Surg Oncol, 2013; 39(5): Pg 517 (Abs No 7)

National meeting of Association of Breast Surgery (ABS), Manchester, UK

 

Recurrence rate after skin sparing mastectomy and immediate reconstruction: an update

Agrawal A, Grewal M, Sneddon P, Sibbering DM, Courtney CA

Eur J Surg Oncol, 2012; 38(5): Pg 436 (Abs No P63)

European Breast Cancer Conference, Vienna, Austria

 

Recurrence rate after skin sparing mastectomy and immediate reconstruction

Agrawal A, Grewal M, Sneddon P, Sibbering DM, Courtney CA

Eur J Cancer, 2012; 47: Suppl 1 (Abs No 596)

National meeting of Association of Breast Surgery (ABS), Bournemouth, UK

 

Predictability of time to progression (TTP) during fulvestrant treatment in breast cancer

Agrawal A, Robertson JFR, Gutteridge E, Ellis IO, Cheung KL, Nicholson RI, Kyme S, Gee JM

1st British Breast Cancer Research Conference Meeting Proc, Nottingham, 2010:1 (Abs No A32), UK

 

Relation of tumour morphology with response during fulvestrant treatment in breast cancer

Agrawal A, Ellis IO, Robertson JFR

1st British Breast Cancer Research Conference Meeting Proc, Nottingham, 2010:16 (Abs No A31), UK
Early therapeutic intervention based on blood tumour markers (TMs) in patients with primary breast cancer (PBC)

Mathew J, Agrawal A, Prinsloo P, Gutteridge E, Merenah E, Cheung KL, Robertson JFR

1st British Breast Cancer Research Conference Meeting Proc, Nottingham, 2010:21 (Abs No A41), UK
Long-term effect of fulvestrant on signalling elements in breast cancer

Agrawal A, Robertson JFR, Gutteridge E, Ellis IO, Cheung KL, Nicholson RI, Kyme S, Gee JM

J Clin Oncol 2010; ASCO Annual Meeting Proc. 28:7s, 2010 (suppl; abstr 1061)

Meeting of the American Society of Clinical Oncology, Chicago, USA

 

Early therapeutic intervention based on blood tumour markers (TMs) in patients with primary breast cancer (PBC)

Robertson JFR, Mathew J, Prinsloo P, Agrawal A, Gutteridge E, Merenah E, Cheung KL

J Clin Oncol 2010; ASCO Annual Meeting Proc. 28:7s, 2010 (suppl; abstr 639)

Meeting of the American Society of Clinical Oncology, Chicago, USA

 

Long-term effect of fulvestrant on hormone receptors and proliferation marker in breast cancer

Agrawal A, Robertson JFR, Gutteridge E, Ellis IO, Cheung KL, Nicholson RI, Gee JMG

Eur J Cancer 2010; 8 (3):111(Abs No 182)

Nottingham International Breast Cancer meeting, UK
Biological profile of oestrogen receptor α positive (ERα+) primary breast cancers in the elderly and their response to primary endocrine therapy

Okunade G, Green AR, Ying M, Agrawal A, Paish EC, Winterbottom L, Hassell K, Morgan DA,

Ellis IO, Cheung KL

J Clin Oncol 2009; ASCO Annual Meeting Proceedings I 27, 15S:e20622

Meeting of the American Society of Clinical Oncology, Chicago, USA

 

Goserelin plus anastrozole (G+A) as first-line systemic therapy for premenopausal estrogen receptor positive (ER+) advanced breast cancer (ABC)– clinical and endocrine data

Agrawal A, Winterbottom L, Robertson JFR, Cheung KL

J Clin Oncol. 2008 June; ASCO Annual Meeting Proceedings 26 Suppl (19): 63s (Abs No1091)

Meeting of the American Society of Clinical Oncology, Chicago, USA
Clinical benefit as a surrogate marker of survival in patients receiving primary endocrine therapy in locally advanced primary breast cancer

Mathew J, Agrawal A, Jackson LR, Robertson JFR, Cheung KL

J Clin Oncol. 2008 June; ASCO Annual Meeting Proceedings 26 Suppl (19): 760s (Abs No 22141)

Meeting of the American Society of Clinical Oncology, Chicago, USA
Primary endocrine therapy in locally advanced breast cancers- Nottingham experience

Mathew J, Agrawal A, Buhari A, Morgan D, Robertson J, Cheung KL

Eur J Surg Oncol. 2007; 33 (9): 1095 (Abs No 21)

Nottingham International Breast Cancer meeting, UK

 

Is the difference between tamoxifen and anastrozole in adjuvant trials applicable to primary endocrine therapy of early operable primary breast cancer in the elderly?

Agrawal A, Ying M, Winterbottom L, Morgan DAL, Ellis IO, Cheung KL

Eur J Cancer. 2007 Sep; 39 Suppl (5):11

Nottingham International Breast Cancer meeting, UK

 

Anastrozole versus Tamoxifen as Primary Endocrine Therapy for Early Operable PrimaryBreast Cancer in the Elderly

Ying M, Agrawal A, Winterbottom L, Morgan DAL, Ellis IO, Cheung KL

J Clin Oncol. 2007 June; ASCO Annual Meeting Proc 25 Suppl (18S): 596s (Abs No 11025)

Meeting of the American Society of Clinical Oncology, Chicago, USA

 

Changes in HER-2 expression in sequential tumour biopsies while on fulvestrant for advanced breast cancer

Agrawal A, Green AR, Paish EC, Cheung KL, Ellis IO, Robertson JFR

Breast Cancer Res. Treat. 2006 Dec; 100 Suppl (1): S158

San Antonio Breast Cancer Conference, USA
Activity of fulvestrant in a subset of estrogen receptor-positive patients with advanced breast cancer that overexpresses HER-2

Robertson JFR, Agrawal A, Paish EC, Cheung KL, Ellis IO

Breast Cancer Res. Treat. 2006 Dec; 100 Suppl (1): S194

San Antonio Breast Cancer Conference, USA
Serum EGFR and HER-2 levels in metastatic breast cancer patients receiving Gefitinib therapy

Allen CL, Chapman CJ, Hitch A, Agrawal A, Cheung KL, Robertson JFR

Breast Cancer Res. Treat. 2006 Dec; 100 Suppl (1): S91

San Antonio Breast Cancer Conference, USA

 

Clinical relevance of “withdrawal therapy” from anti-estrogens in breast cancer

Agrawal A, Robertson JFR, Cheung KL.

Eur J Surg Oncol. 2006 Dec; 32(9): 1035

British Association of Surgical Oncology, London, UK

 

Can CT scan replace bone scan in detecting bony metastases from breast cancer? A

prospective audit

Agrawal A, Bristow AR, Burrell HC, Cornford EJ, Evans AJ, James JJ, Hamilton L, Cheung KL

Eur J Surg Oncol. 2006 Dec; 32(9): 1032

British Association of Surgical Oncology, London, UK

 

Oesophagogastric cancers secondary to a breast primary do not require resection

Ayantunde AA, Agrawal A, Parsons SL, Welch NT

J of Hepatobiliary Pancreat Surg. 2006 September; 8 Suppl (2): 193 (World Congress of the

International Hepato-Pancreato-Biliary Association, 03-07 September 2006, Edinburgh, UK)

 

Bone turnover markers in postmenopausal breast cancer patients treated with Fulvestrant

Agrawal A, Hannon RE, Cheung KL, Eastell R, Robertson JFR

J Clin Oncol. 2006 June; ASCO Annual Meeting Proc 24 Suppl (18): 47s

Meeting of the American Society of Clinical Oncology, Atlanta, USA

 

CA15.3 and its correlation with clinical response in advanced breast cancer patients with Fulvestrant therapy

Robertson JFR, Agrawal A, Gutteridge E, Cheung KL, Evans AJ

J Clin Oncol. 2006 June; ASCO Annual Meeting Proc 24 Suppl (18): 38s

Meeting of the American Society of Clinical Oncology, Atlanta, USA

 

Primary endocrine therapy with anastrozole for early operable primary breast cancer in the elderly – early clinical and biological data

Cheung KL, Ying MWL, Green AR, Agrawal A, Paish EC, Winterbottom L, Ellis IO

J Clin Oncol. 2006 June; ASCO Annual Meeting Proc 24 Suppl (18): 579s

Meeting of the American Society of Clinical Oncology, Atlanta, USA

 

Biological characteristics of oestrogen receptor positive early operable primary breast cancer in the elderly

Ying MWL, Green AR, Agrawal A, Paish EC, Morgan DAL, Ellis IO, Cheung KL

J Clin Oncol. 2006 June; ASCO Annual Meeting Proc 24 Suppl (18): 587s

Meeting of the American Society of Clinical Oncology, Atlanta, USA

 

Continued use of goserelin to achieve ovarian function suppression in combination with a further aromatase inhibitor (exemestane) following prior treatment with anastrozole and/or tamoxifen in premenopausal women with ER positive advanced breast cancer

Agrawal A, Robertson JFR, Winterbottom L, Cheung K.

Eur J Cancer. 2006 Mar; 4 Suppl (2): 167

Nottingham International Breast Cancer meeting, UK

 

Clinical experience with Fulvestrant: The Nottingham experience in postmenopausal

women with advanced breast cancer (ABC) Nottingham’s experience       

Gutteridge E, Agrawal A, Hyman-Taylor P, Evans A,Wakeling A Robertson JFR

Eur J Cancer. 2006 Mar; 4 Suppl (2): 162

Nottingham International Breast Cancer meeting, UK

 

Efficacy and tolerability of gefitinib in oestrogen receptor negative and tamoxifen resistant oestrogen receptor positive locally advanced or metastatic breast cancer

Agrawal A, Gutteridge E, Cheung KL, Hyman-Taylor P, Robertson JFR

Breast Cancer Res. Treat. 2005 Dec; 94 Suppl (1): S61

San Antonio International Breast Cancer Conference, USA

 

Response to further endocrine therapies following de novo or acquired resistance to first line endocrine therapy for advanced breast cancer

Agrawal A, Mustafa T, Gutteridge E, Robertson JFR, Cheung KL

Eur J Cancer. 2005 Sep; 37 Suppl (5): 8

Nottingham International Breast Cancer meeting, UK

 

High dose oestrogen (HDE) as an endocrine therapy option for advanced breast cancer (ABC)

Agrawal A, Robertson JFR, Cheung KL

Eur J Cancer. 2005 Sep; 37 Suppl (5): 8

Nottingham International Breast Cancer meeting, UK